While often effective, there is the risk of complications with CABG and PTCA. These procedures are also costly because they require skilled personnel, sophisticated equipment, and hospitalization. Thus, the probability of long-term success should be optimized for maximum patient benefit and the best use of healthcare resources. Short-and long-term failure rates for these procedures have Serial coronary arteriography in patients with underlying coronary artery disease has been used in a number of clinical trials designed to determine whether specific interventions can prevent the progression of coronary atherosclerosis or even result in regression. Most of these studies have been directed toward interventions that lower total and LDL cholesterol. In addition, several of these interventions raised HDL cholesterol levels: diet, lipid-altering drugs, major lifestyle change, behavioral modification, and ileal bypass surgery. Studies on the ability of calcium entry blockers to prevent atherosclerosis have also been undertaken. Although a global scoring system by an arteriographic reading panel that gave an overall measure of atherosclerotic change was used in some trials,34,45 serial quantitative coronary arteriography provides a more reproducible and accurate method for following serial changes and is increasingly being used.
An overview of these trials46 demonstrates that progression can be slowed significantly, that regression can be demonstrated in a minority of patients, and that plaques prone to rupture can also be stabilized, preventing coronary events. The favorable serial changes in the coronary circulation correlate with the ability to both lower LDL cholesterol and raise HDL cholesterol. Furthermore, in the POSCH Trial, the global coronary change score, determined after repeat serial coronary arteriography 3 years after randomization, predicted subsequent coronary events. 45 Even modest levels of physical activity may offer benefit.57 The patient should be asked in some detail about his or her level of physical exertion in both occupational and nonoccupational activities before the onset of coronary symptoms. The patient should also be specifically asked to recall the frequency of physical activity during the previous week and amount of exercise engaged in during leisure time. Most patients with long-term coronary artery disease should be encouraged to participate in physical activity.58 However, exercise should be safe, as indicated by the patient's history or further testing (eg, exercise ECG). The treatment goal is difficult to define scientifically, but a level of exercise vigorous enough to make the patient breathe hard and/or sweat, performed at least three times per week, is a useful rule of thumb. An alternative approach for the patient with known coronary artery disease is level walking at a brisk pace for at least 1 1/2 to 2 miles a day, three times per week as a minimum (preferably daily). Smoking
A thorough history of smoking should be obtained, including duration and frequency of past and current use of cigarettes or other forms of tobacco. This assessment of likelihood for recidivism in the patient who has recently quit smoking is important. Symptoms of nicotine withdrawal and the presence of other smokers at work and/or at home may lead to recidivism. Smoking or a high likelihood of recidivism is justification for further Obesity An assessment of obesity in CABG patients has important implications for both in-hospital and follow-up periods. Obesity is associated with prolonged total bypass time.5960 Through multivariate analysis obesity was found to be an independent risk factor for perioperative morbidity, including respiratory failure, leg wound complications, myocardial infarction, arrhythmias, and sternal dehiscence. With a mean follow-up time of 36.9 months, obese patients had a greater incidence of significant recurrent angina associated with further weight gain. Even mild obesity is associated with impaired lung function and increased alveolar arterial oxygen gradients in patients undergoing bypass surgery.61 Height and weight should be measured and recorded for all patients, and relative body weight should be correlated to tables of standard weight to height to calculate percent ideal body weight. Patients whose body weight is greater than 130% of ideal should be targeted for intensive diet and exercise intervention after revascularization.
Diabetes Mellitus
The effects of diabetes mellitus on the atherosclerotic process are multifactorial and result from lipid abnormalities, abnormalities of platelet function, and abnormalities of other metabolic pathways. 
Management and Follow-up of Risk Factors

Overview
Role of the Physician Cardiovascular specialists should lead the effort to establish comprehensive and coordinated programs in risk factor modification. The opportunity and responsibility to promote good health as well as disease prevention lies with physicians and should not be delegated. All patients who undergo surgical and nonsurgical coronary revascularization come to the cardiovascular specialist with advanced disease for which risk factor modification has beneficial effects on long-term morbidity and mortality. The general population receives a variety of medical and nonmedical advice on the importance of coronary risk factor modification. The immediate and long-term importance of risk factor identification and modification must be stressed to patients with coronary artery disease and their families. Complete risk factor assessments, including a fasting lipid profile, should be performed in all first-degree relatives of patients with onset of coronary artery disease before age 55 through 60, including children older than 2 years. The cardiovascular specialist should take responsibility for carrying out these risk factor assessments, either personally or by other healthcare providers. The physician should not miss the opportunity to emphasize the importance of specific risk factor modification behaviors to individual patients. The physician should also try to ensure successful compliance. Patients and their families are likely to be more receptive to these concepts at the time of major interventions, when there is at least a temporary disruption in normal lifestyle.
After assessment of risk, the role and responsibility of the cardiovascular specialist is to emphasize the importance of nonpharmacologic intervention, to develop with the patient the overall treatment, to establish treatment goals, and to provide a means for monitoring or follow-up. The physician's involvement in the intervention plan is crucial to its implementation; the patient needs to understand the entire treatment plan, both nonpharmacologic and pharmacologic, as well as the role of other healthcare professionals.
Role of Other Healthcare Professionals
Counseling can entail a considerable amount of time, including multiple inpatient sessions and follow-up with the patient and family members. A multidisciplinary team of nurses, registered dietitians, and exercise physiologists has the advantage of offering specific skills in counseling, nutrition, exercise, and smoking cessation. The team requires coordination, usually with the help of a team leader, and benefits from communication between the physician, team members, and the patient about the overall treatment plan and goals.
Role of the Family
The patient usually does not eat, smoke, exercise, or take medications in isolation but usually as part of a family unit. Family members are valuable members of the intervention team and need to encourage the patient toward treatment goals. It may be necessary to include the family in the intervention by changing family eating, smoking, or exercise habits in order for the patient to continue interventions initiated in the hospital. Such interventions are usually valuable for family members because they often share the patient's risk factors. Screening for risk factor aggregation in siblings and children will further encourage modification of lifestyle for the patient and family.
Role of the Primary Care Provider
The revascularization procedure brings the patient in contact with the inpatient team for a relatively brief period. It is likely that long-term follow-up of these interventions will be performed by the primary care physician. Consultation notes or referral letters from the cardiovascular specialist should describe the treatment plan to reduce risk factors, the goals of interventions, steps taken in the hospital, and the need for follow-up. Role of Health Insurers, Employers, and Government Agencies Support is required for posthospitalization risk factor management programs, including cardiac rehabilitation programs, smoking cessation programs, lipid profile testing, diet and drug therapies to reduce blood pressure and serum lipids, and public education programs. Continued reinforcement of these principles is important to improve success rates and help reduce the otherwise negative impact of recurrent disease on healthcare expenditures and disability benefits. Specific Nonpharmacologic Interventions Fat-Modified Diet Because most patients with coronary artery disease have an LDL cholesterol level greater than 100 mg/dL (2.6 mmol/L) and the diet recommended for all Americans is a fat-modified diet, steps should be taken to implement the Step II diet recommended by the National Cholesterol Education Program.53 The Step II diet limits saturated fat to less than 7% of calories, total fat to less than 30% of calories, and dietary cholesterol to less than 200 mg/d. Several strategies foster implementation of this diet:
1. The inpatient diet should be consistent with the Step II diet.
2. A registered dietitian (RD) or other qualified nutritional counselor should meet with the patient and the family member who shops and cooks for the family. An assessment of the family's current eating patterns may be helpful in counseling.
3. Literacy-appropriate brochures or other written materials should be given to the patient and family to help them make correct food choices.
4. The cardiovascular specialist should recommend to the primary care physician long-term follow-up of recommended dietary changes by an RD or qualified nutritionist. The RD may also supervise additional dietary changes. Blood Pressure Control
The patient who had hypertension before a coronary event may benefit from continued intervention consistent with the Fifth Joint National Committee Report.56 Nonpharmacologic interventions should focus on restriction of dietary sodium and weight reduction. Several specific strategies can be recommended:
1. The inpatient diet should be consistent with a moderate sodium restriction (2 to 3 g of sodium per day), with greater restrictions if necessary for control of heart failure, etc.
2. An RD or other qualified nutritional counselor should meet with the patient and key family members to give advice about low-salt diets, avoidance of excessive alcohol intake (more than 1 oz [30 mL] per day), and caloric restriction.
3. Literacy-appropriate brochures and other written materials should be available to help the patient understand the importance of salt restriction, avoidance of excessive alcohol intake, and weight loss.
4. Initiation of phase I cardiac rehabilitation and referral to an outpatient cardiac rehabilitation exercise program should emphasize regular, safe physical activity.
Physical Activity
The return to usual (or greater) levels of physical activity has important physical, psychological, occupational, and social consequences for the typical patient with coronary artery disease. Cardiac rehabilitation programs appear to be associated with reduced recurrence of cardiac events and death and should be incorporated into the overall risk reduction program. A phase I cardiac rehabilitation program should be initiated while the patient is in the hospital. Referral to phase II and III programs or recommendation to the primary care physician for referral is encouraged. The cardiac rehabilitation program should be relatively convenient for the patient. Close contact with the primary care physician about the patient's progress should be 
